I am confused, maybe you could sort me out. For the half year to...

First 5 Last

Share
Profile

Follow
dallasaustin

75 Posts.

3

06/03/18

20:51

Post #: 31571443
Share

Originally posted by pCap ↑

I did some more digging on the H1 results:

- H1 fixed charge cover of 1.33x was low because its a rolling 12 month covenant which includes the weak H2 FY2017 result. Accordingly, it should automatically strengthen to ~1.4x at the FY (assuming they meet guidance);
- In terms of H2 guidance, there will be about $1m of costs associated with the Hong Kong direct sourcing office in H2 for which no benefit will flow until FY2019. However, this expenditure should provide significant future upside if well executed (consider what it did for Kmart).
- Apparently the company is working with consultants to improve the group's cost position in the second half. Any benefits from this should be upside to guidance;
- Its also worth noting that although H2 guidance looks conservative, it will mean a c$7m improvement in H2 EBIT, which isn't bad given the additional costs mentioned above. (although I still think its conservative).

I agree with Didak that the first half was a 10/10 for mgt, and am convinced there's a huge amount of s/p upside from here - just need to sit tight.

Expand

I am confused, maybe you could sort me out. For the half year to 31.12.16 NPAT $17.5m
for the second half to 30.6.17 Loss of $5.2 m therefore NPAT for year to 30.6.17
NPAT $12.3m. For the half year to 31.12.17 NPAT $17.7 m. My confusion is that
the guidance for the full year to 30.6.18 is NPAT $16.5 to $17.5 million. Does that not indicate a loss in the second half. Please explain Thanks

TRS Price at posting: $7.24 Sentiment: Buy Disclosure: Not Held
Upvote

0 Great analysis

Reply